Venlafaxine and Bupropione in diabetic patients with depressio
Phase 2
Recruiting
- Conditions
- Type 2 diabetes mellitus.Type 2 diabetes mellitus
- Registration Number
- IRCT20150630022991N12
- Lead Sponsor
- Babol University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Age 18 years and over
The presence of depressive symptoms in psychiatric clinical interview
Confirmation of type 2 diabetes mellitus based on the diagnosis of research´s endocrinologist
Exclusion Criteria
Pregnancy and breast feeding
Previous history of high mood, serious suicidal ideation and dementia
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Depressive symptoms. Timepoint: At baseline and at the end of the 12th week after intervention. Method of measurement: Beck Depression Inventory.;Blood glucose. Timepoint: At baseline and at the end of the 12th week after intervention. Method of measurement: Fasting blood glucose; 2 hours post-prandial blood glucose and hemoglobin A1C.
- Secondary Outcome Measures
Name Time Method Drug side effects. Timepoint: At baseline and at the end of the 12th week after intervention. Method of measurement: Medical visit.